Newsroom · Sioux Falls

Medicare Part B Injections & Infusions in Sioux Falls 2026: When Your Drug Is a Medical Cost, Not a Pharmacy Bill

The drug your doctor gives you in the clinic and the drug you pick up at the pharmacy follow completely different Medicare rules — and the financial exposure gap between them can be substantial.

Big Sioux Benefits Data Desk

Published July 17, 2026 · 10 min read · Sourced from CMS.gov

When your doctor gives you a drug in the office — an infusion at Sanford's or Avera's outpatient center, an injection administered by your rheumatologist, or a biologic therapy given at an oncology clinic — Medicare bills it under Part B, not Part D. That single fact changes every number in your cost-sharing: which deductible applies, the percentage you owe, and whether you have any annual ceiling at all.

Every figure in this article comes from public federal sources: the CMS 2025 Medicare Parts A & B Premiums and Deductibles (Fact Sheet), the CMS Medicare Advantage / Part D Landscape (PY2026), the CMS standardized Medigap plan guide, and CDC PLACES: Local Data for Better Health, County 2023 for Minnehaha County. No invented numbers.

The Part B vs. Part D Drug Split — and Why One Has No Ceiling

Medicare divides drug coverage between two programs with fundamentally different rules:

• Part D (drug plan) covers drugs you dispense yourself — prescription bottles from the pharmacy, mail-order refills, and inhalers you use at home. In 2026, Part D has a hard out-of-pocket cap of $2,100 — the first annual ceiling in Part D history, a genuine breakthrough for high-spending beneficiaries.
• Part B (medical benefit) covers drugs that require administration by a health care provider: infusions at a clinic or hospital outpatient center, injections given in a physician's office, and biologics that need clinical supervision. These follow medical cost-sharing rules — the same rules that govern a doctor visit or outpatient procedure — with no annual out-of-pocket ceiling under Original Medicare.

The practical trigger is usually straightforward: if a nurse or doctor administers the drug during a medical visit, it is almost always Part B. If you take it home and self-administer, it is almost always Part D. The same molecule can land in either bucket depending on how it is dispensed — and which bucket determines exactly what you pay.

Your 20% Exposure — With No Annual Ceiling

Under Original Medicare, Part B cost-sharing has two components: an annual deductible you pay once, and then a coinsurance rate applied to every covered charge for the rest of the year.

A single 20% coinsurance on one visit is often manageable. But infusion therapies and biologic injections are frequently administered on a recurring schedule — monthly, every six weeks, or quarterly — meaning the 20% compounds across every session with nothing to stop it. The table below shows how that math stacks at different approved-amount levels:

Source: CMS 2025 Medicare Parts A & B Premiums and Deductibles (Fact Sheet). Rows show illustrative calculations using the CMS-published 20% Part B coinsurance rate; amounts apply after the $257 annual deductible is satisfied.

These calculations assume the annual deductible is already met. If you receive treatments on a recurring schedule throughout the year, your 20% applies to each session — compounding against any treatment that carries a high Medicare-approved rate.

Which Minnehaha County Conditions Create the Most Part B Drug Exposure

Not every chronic condition requires Part B drugs. But several of the most common conditions in Sioux Falls are treated with drugs administered in clinical settings — not dispensed at the pharmacy — putting a meaningful share of Minnehaha County's 39,532 Medicare beneficiaries in the Part B drug exposure zone.

Source: CDC PLACES: Local Data for Better Health, County 2023 (2023), Minnehaha County adults. Prevalence rates do not imply all patients with these conditions use Part B drugs.

Sources: CDC PLACES: Local Data for Better Health, County 2023 (2023); CMS Medicare Monthly Enrollment by County (2026). Estimated beneficiaries = county prevalence × 39,532 total Minnehaha County enrollees. Not all patients with these conditions use Part B drugs; consult your provider.

Arthritis is the standout exposure. With 22.9% of Minnehaha County adults affected — an estimated 9,053 Medicare beneficiaries — rheumatoid arthritis and certain other inflammatory conditions are among the most common reasons patients receive biologic therapies administered by infusion or injection in a clinical setting. Those biologics are Part B charges. Cancer treatments — affecting an estimated 3,162 local beneficiaries based on the 8.0% rate — involve IV chemotherapy and immunotherapy that are similarly Part B. COPD (5.6%) and coronary heart disease (5.5%) add another estimated 4,400-plus beneficiaries who may encounter Part B drug charges for specialty respiratory and cardiac treatments.

How Medigap Plans Handle the Part B Drug Bill

Medigap plans are standardized by federal law — the coverage matrix is set by CMS, not by individual carriers. Every plan of the same letter covers the same benefits. The column that matters for Part B drugs is Part B coinsurance: does the plan pay your 20%?

Source: CMS — Choosing a Medigap Policy (Publication 02110) (CMS Publication 02110), standardized per 42 CFR §403.205. Plans C and F are not available to beneficiaries first eligible for Medicare on or after January 1, 2020.

Plan G is the most comprehensive choice for beneficiaries who receive Part B drugs regularly. It covers the full 20% Part B coinsurance, the $1,632 Part A deductible per benefit period, SNF coinsurance (days 21–100), excess charges from non-participating providers, and foreign travel emergency coverage. After you pay the $257 annual Part B deductible, your share of every covered infusion or injection is $0 for the rest of the year.

Plan N also covers the full 20% coinsurance but adds a $20 copay for office visits and a $50 copay for emergency room visits. For infusion visits, whether the $20 copay applies depends on how your provider codes the encounter — an infusion billed primarily as a drug administration may or may not trigger the copay. Plan N premiums run lower than Plan G premiums, making it a potential fit for beneficiaries who want coinsurance protection at a lower monthly cost and can accept the copay structure.

Plans K and L pay only 50% and 75% of Part B coinsurance respectively, leaving a remaining 10% and 5% share on your side. They carry their own annual out-of-pocket limits ($7,220 for Plan K, $3,610 for Plan L) and lower premiums — but for beneficiaries receiving regular high-cost infusions, the partial coinsurance coverage creates a meaningful exposure gap compared to Plan G or N.

How the 5 Sioux Falls Medicare Advantage PPOs Compare

Medicare Advantage PPOs take a different structural approach: they bundle your coverage, apply their own copay and coinsurance schedules, and cap your total annual medical spending with a maximum out-of-pocket limit (MOOP). That ceiling is a real protection for high-cost infusion schedules. Here is the complete 2026 PPO lineup for Minnehaha County:

Source: CMS Medicare Advantage / Part D Landscape (PY2026) & CMS Medicare Advantage & Part D Star Ratings (2026), Minnehaha County 2026.

For Part B drug users, the Advantage MOOP is the headline benefit: once you hit the plan's annual ceiling, the plan covers 100% of additional costs for the year. The trade-offs are important to weigh. First, network: the infusion center and referring physician must both be in-network for the lowest cost-sharing — out-of-network use under a PPO may cost significantly more. Second, prior authorization: specialty biologics commonly require pre-approval; if the plan denies a request, you have appeal rights but the process takes time. Third, formulary rules: even for Part B drugs, plans may apply utilization management protocols.

Where You Receive the Drug Matters — The Sanford and Avera Connection

In Sioux Falls, the majority of specialty infusions occur at Sanford USD Medical Center's outpatient facilities or Avera McKennan's infusion center — the two systems that anchor local specialty care. CMS Hospital Compare overall star ratings confirm both are strong:

Source: CMS Hospital Compare — Overall Star Ratings.

Both Sanford (5★) and Avera (4★) are Medicare-participating providers — meaning they accept Medicare's approved rates and cannot add excess charges on top of the standard 20% coinsurance. For beneficiaries on Original Medicare with Plan G, that means the protection is complete: 20% coinsurance covered by the plan, and no excess charge risk from either system.

The network question becomes more specific under Medicare Advantage. Sanford Health runs two of the five local PPOs — Align ChoicePlus ($0, $350 deductible) and Align ChoiceElite ($66, $300 deductible) — and those plans are structured around the Sanford network. Aetna and Wellmark serve both systems but always verify your specific infusion center, your referring physician, and your specialist are all in any plan's 2026 directory before you enroll. Network participation can change between plan years.

What to Watch for Part B Drug Coverage in 2026

1. Ask your billing office whether each treatment is Part B or Part D. If a drug is administered at a clinic visit, ask them to confirm whether it bills under Part B or Part D. The answer determines which deductible applies, which cost-sharing rules govern, and which plan protections help. Do this before the first treatment if possible.
2. Compare Medigap Plan G premiums against your expected infusion frequency. If you receive a Part B drug monthly or more often, Plan G's premium may be more cost-effective than absorbing the uncapped 20% across the full year — especially for ongoing biologic or specialty-drug schedules. Run the math against your specific treatment cadence.
3. Confirm prior authorization rules before AEP (Oct 15–Dec 7). If you're considering a Medicare Advantage PPO, ask the plan directly whether your current treatments require prior authorization and whether they've been approved for your specific diagnosis code. Surprises after enrollment are harder to resolve.
4. Check both Sanford and Avera network participation under every PPO you consider. If you receive care across both systems — or may need to in the future — confirm each location and provider is in-network under any Advantage plan you evaluate. Out-of-network PPO costs for infusions can be substantially higher.
5. Remember: strong Part D coverage does not mean strong Part B drug protection. The $2,100 cap is a pharmacy backstop; it does not cross over to infusions and injections. Beneficiaries who carry both heavy pharmacy and infusion costs need to evaluate both sides of their coverage picture — separately.

How we know this: Big Sioux Benefits runs every article through a data desk that cross-references the CMS Parts A & B premium and deductible fact sheet, CMS Medigap standardized plan publications, the PY2026 Medicare Advantage plan landscape for Minnehaha County, CMS Hospital Compare quality ratings, and CDC PLACES 2023 local health data — built by Strategic AI Architects. Every figure here comes from a public federal dataset. This is education, not advice; confirm your specific plan, costs, and eligibility with a licensed agent or Medicare.gov. We do not offer every plan available in your area — any information we provide is limited to those plans we do offer. Please contact Medicare.gov or 1‑800‑MEDICARE to get information on all of your options. We take no payment from any carrier to feature a plan.